Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Del Bene

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Obstetrics and Gynecology|August 15, 1981
Giardiasis in pregnancyA K Kreutner, V E Del Bene, M S Amstey
Antimicrobial Agents and Chemotherapy|February 1, 1981
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistanceJ E Brown, V E Del Bene, C D Collins
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2000
Medical University of South Carolina College of MedicineA V Blue, V E Del Bene, D R Garr
Reviews of Infectious Diseases|January 1, 1979
Cefoxitin therapy for surgical patientsW M Rambo, V E Del Bene, D K Delamar
Journal of Clinical Microbiology|March 1, 1987
Factors affecting antimicrobial susceptibility of Fusobacterium speciesM D Rowland, V E Del Bene, J W Lewis
Southern Medical Journal|August 1, 1977
Bacterial flora of patients with prematurely ruptured membranesV E Del Bene, E Moore, M Rogers, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1993
Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycinsR L White, M B Kays, L V Friedrich, et al.
Journal of Medical Education|September 1, 1985
Effect of a breast examination teaching unit in physical diagnosis on medical students' practicesI K Smith, V E Del Bene, G A Fleming, et al.
Clinical Therapeutics|September 1, 1991
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic propertiesM B Kays, R L White, L V Friedrich, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistanceV E Del Bene, P J Carek, J A Twitty, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|August 15, 1981
Giardiasis in pregnancyA K Kreutner, V E Del Bene, M S Amstey
Antimicrobial Agents and Chemotherapy|February 1, 1981
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistanceJ E Brown, V E Del Bene, C D Collins
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2000
Medical University of South Carolina College of MedicineA V Blue, V E Del Bene, D R Garr
Reviews of Infectious Diseases|January 1, 1979
Cefoxitin therapy for surgical patientsW M Rambo, V E Del Bene, D K Delamar
Journal of Clinical Microbiology|March 1, 1987
Factors affecting antimicrobial susceptibility of Fusobacterium speciesM D Rowland, V E Del Bene, J W Lewis
Southern Medical Journal|August 1, 1977
Bacterial flora of patients with prematurely ruptured membranesV E Del Bene, E Moore, M Rogers, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1993
Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycinsR L White, M B Kays, L V Friedrich, et al.
Journal of Medical Education|September 1, 1985
Effect of a breast examination teaching unit in physical diagnosis on medical students' practicesI K Smith, V E Del Bene, G A Fleming, et al.
Clinical Therapeutics|September 1, 1991
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic propertiesM B Kays, R L White, L V Friedrich, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistanceV E Del Bene, P J Carek, J A Twitty, et al.
Pageof 3